Guardant Health Inc
Guardant Health Inc (GH) Unusual Options Activity Today
GH options volume power reached 9x on the previous trading day. The highest reading was on the $100 PUT expiring 2027-03-19.
Read more
Checking GH unusual options activity helps you spot when traders are making outsized bets on Guardant Health Inc before the broader market catches on. Guardant Health Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor GH unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching GH unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking GH unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and GH unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials.
In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Catalysts rarely arrive without a footprint, and GH unusual options activity is often where that footprint shows up first. Our scanner tracks Guardant Health Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at GH unusual options volume on the call side or chasing put sweeps, Guardant Health Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 100.00 | 76.00 | 80.20 | 78.10 | 124% | 15 | 43 | 34.88% |
| 175.00 | 7.40 | 9.90 | 8.65 | 47% | 32 | 182 | 17.58% |
| 195.00 | 1.90 | 2.45 | 2.18 | 50% | 36 | 505 | 7.13% |
| 170.00 | 11.30 | 14.20 | 12.75 | 55% | 6 | 139 | 4.32% |
| 185.00 | 3.50 | 5.70 | 4.60 | 49% | 2 | 142 | 1.41% |
| 190.00 | 13.90 | 16.40 | 15.15 | 50% | 1 | 3 | 33.33% |
| 160.00 | 1.40 | 2.00 | 1.70 | 52% | 13 | 249 | 5.22% |
| 170.00 | 3.90 | 4.70 | 4.30 | 52% | 12 | 379 | 3.17% |
| 100.00 | — | 2.15 | 2.15 | 197% | 6 | 317 | 1.89% |
| 125.00 | 0.05 | 0.10 | 0.08 | 71% | 1 | 109 | 0.92% |
As of September 29, 2026
Spot unusual options activity before it moves
Track GH options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→